Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
253.25
-2.29 (-0.90%)
Jun 15, 2026, 4:00 PM EDT - Market closed
Ligand Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 10 analysts polled by S&P Global, Ligand Pharmaceuticals stock has a consensus rating of "Strong Buy" and an average price target of $277.6. The average 1-year stock price forecast is 9.62% higher than the current stock price, while the lowest is $247 (-2.47%) and the highest is $330 (+30.31%).
Price Target: $277.6 (+9.62%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Ligand Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 3, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $266 | Buy | Maintains | $266 | +5.03% | Jun 2, 2026 |
| RBC Capital | RBC Capital | Buy Reiterates $262 | Buy | Reiterates | $262 | +3.46% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $289 | Buy | Reiterates | $289 | +14.12% | May 7, 2026 |
| Stifel Nicolaus | Stifel Nicolaus | Buy Reiterates $230 → $255 | Buy | Reiterates | $230 → $255 | +0.69% | Apr 27, 2026 |
Financial Forecast
Revenue This Year
286.10M
from 268.09M
Increased by 6.72%
Revenue Next Year
363.63M
from 286.10M
Increased by 27.10%
EPS This Year
9.10
from 8.13
Increased by 11.95%
EPS Next Year
11.32
from 9.10
Increased by 24.34%
EPS and Forward PE are based on non-GAAP adjusted numbers.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 309.7M | ||
| Avg | 286.1M | ||
| Low | 273.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 15.5% | ||
| Avg | 6.7% | ||
| Low | 2.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 9.10 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | 11.9% | ||
| Low | - |